Skip to Main Content

Paper Details

Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.
Psychiatry Res
7
2020
Cannabis, IFN, IL-6, Inflammatory abnormalities, Positive and Negative Syndrome, Psychosis, acute psychosis, agitation, cannabinoid, cannabinoids, chronic psychotic disorders, interferon, interleukin-6, participants, patients, psychosis, psychotic
Author NameAffiliation
Amy J SwiftIcahn School of Medicine at Mount Sinai
Madhu MazumdarIcahn School of Medicine at Mount Sinai
Nicolas F FernandezIcahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai, USA Precision Immunology Institute
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai, USA Precision Immunology Institute
Yasmin L HurdIcahn School of Medicine at Mount Sinai, USA Addiction Institute at Mount Sinai
  • 1 - 6

Datasets

Release 1.2